Markus Sieger
CIK: 0001337143
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (25.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 28, 2026RFL
Rafael Holdings, Inc.
Award(A)Direct29.5K shares at avg. $1.27$38K - May 27, 2025RFL
Rafael Holdings, Inc.
In-the-Money(X)Direct35K shares at avg. $1.28$45K - Feb 27, 2025CYTH
Cyclo Therapeutics, Inc.
Award(A)Direct58.1K shares- - Nov 15, 2024CYTH
Cyclo Therapeutics, Inc.
Award(A)Direct35K shares-
1-4 of 4 transactions
About Sieger Markus
Sieger Markus (SEC CIK 0001337143) files insider reports with the SEC as Director of Rafael Holdings, Inc. (RFL) and Director of Cyclo Therapeutics, Inc. (CYTH).
Signal8 holds 5 ownership filings by Sieger Markus (1 Form 3, 4 Form 4), filed between Nov 18, 2024 and Jan 30, 2026. Those filings report 4 transactions, from Nov 15, 2024 to Jan 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Sieger Markus's filings is in NEWARK, NJ.
Recent filings by Sieger Markus
Other insiders filing for Rafael Holdings, Inc. (RFL)
- Polinsky David, Chief Financial Officer
- JONAS HOWARD S, Exec Chairman, CEO & President
- WEISS MICHAEL J, Director
- STEIN MARK N, Director
- GRAYSON ALAN, Director
- Fine Joshua M, Chief Operating Officer